Finance

Lists
Outlook: 92.9% bullish·0.0% bearish
Go to analysis
STE:NYSE
Steris PLC
$257.17
+0.09%
(+0.23) 1D
Nov 10, 1:42:56 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STE...
Open
$255.96
High
$258.11
Low
$251.97
Mkt. cap
24.97B
Avg. vol.
782.20K
Volume
279.22K
Dividend
1.07%
Quarterly dividend
$0.69
Ex-dividend date
Sep 4, 2026
P/E ratio
30.51
52-wk high
$269.44
52-wk low
$195.14
EPS
$8.43
Beta
0.86
Shares outstanding
97.11M
No. of employees
18K
Open
$255.96
High
$258.11
Low
$251.97
Mkt. cap
24.97B
Avg. vol.
782.20K
Volume
279.22K
Dividend
1.07%
Quarterly dividend
$0.69
Ex-dividend date
Sep 4, 2026
P/E ratio
30.51
52-wk high
$269.44
52-wk low
$195.14
EPS
$8.43
Beta
0.86
Shares outstanding
97.11M
No. of employees
18K
News stories
From web sources and news partners
Profile
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018. Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the president and CEO is Daniel A. Carestio. Wikipedia
About Steris PLC
CEODan Carestio
Employees17.9K
Founded1985
Headquarters-
SectorHealth Care
IndustryMedical device
Websitehealthcare.steris.com
Analyst ratings
Based on 3 analysts giving stock ratings to STE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for STE in the last 3 months.
Highest
Current $257.17
$290.00 (+12.77%)
Average
$283.00 (+10.04%)
Lowest
$275.00 (+6.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Wood
UBS
Buy
Maintained
$290.00
+12.8%
11/06/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
$284.00
+10.4%
11/06/2026
Jason Bednar
Piper Sandler
Buy
Maintained
$275.00
+6.9%
11/05/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/06/2026
Last report
Nov 5, 2026
Fiscal period
Q2 2027
$2.94 / $2.68
+9.83%beat
Revenue / Est. (USD)
1.59B / 1.56B
+1.76%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.50B
1.59B
1.49B
1.59B
Cost of goods sold
841.00M
890.60M
808.50M
890.40M
Cost of revenue
841.00M
890.60M
808.50M
890.40M
Research and development expenses
29.50M
28.80M
28.60M
31.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
349.00M
350.70M
369.70M
362.00M
Operating expense
378.50M
379.50M
398.30M
393.50M
Total operating expenses
1.22B
1.27B
1.21B
1.28B
Operating income
276.70M
318.30M
285.90M
304.70M
Other non operating income
-3.40M
-300.00K
300.00K
1.30M
EBT including unusual items
257.90M
304.50M
273.50M
288.00M
EBT excluding unusual items
261.30M
305.90M
273.30M
298.40M
Income tax expense
63.50M
84.20M
72.50M
73.90M
Effective tax rate
24.62%
27.65%
26.51%
25.66%
Other operating expenses
-
-
-
-
Net income
192.90M
220.20M
200.10M
213.70M
Net profit margin
12.89%
13.86%
13.41%
13.45%
Earnings per share
2.53
2.83
2.59
2.94
Interest and investment income
2.90M
3.00M
2.90M
3.60M
Interest expense
-14.90M
-15.10M
-15.80M
-11.20M
Net interest expenses
-12.00M
-12.10M
-12.90M
-7.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
398.60M
442.20M
409.70M
430.20M
Gain or loss from assets sale
3.20M
-300.00K
-
14.50M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps